Eosinophil peroxidase, GATA3, and T-bet as tissue biomarkers in chronic rhinosinusitis - 06/06/19
Doi : 10.1016/j.jaci.2019.01.038
Devyani Lal, MD a, Benjamin L. Wright, MD b, c, Kelly P. Shim, BS c, Matthew A. Zarka, MD d, James J. Lee, PhD e, †, Yu-Hui Chang, PhD f, Sergei I. Ochkur, PhD e, Rohit Divekar, MBBS, PhD g, Alfred D. Doyle, PhD b, Elizabeth A. Jacobsen, PhD b, e, Hirohito Kita, MD g, h, i, Matthew A. Rank, MD a, b, c 
a Department of Otolaryngology, Mayo Clinic, Phoenix, Ariz
b Division of Allergy, Asthma, and Clinical Immunology, Mayo Clinic, Scottsdale, Ariz
c Division of Pulmonology, Phoenix Children's Hospital, Phoenix, Ariz
d Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Ariz
e Department of Biochemistry and Molecular Biology, Mayo Clinic, Scottsdale, Ariz
f Department of Biostatistics, Mayo Clinic, Scottsdale, Ariz
g Division of Allergic Diseases, Mayo Clinic, Rochester, Minn
h Department of Immunology, Mayo Clinic, Rochester, Minn
i Department of Otorhinolaryngology, Mayo Clinic, Rochester, Minn
| Supported by the Mayo Clinic Foundation. |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2019
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 143 - N° 6
P. 2284 - juin 2019 Retour au numéro
Article précédent
- Regulation of ectodomain shedding of ADAM33 in vitro and in vivo
- Elizabeth R. Davies, Laura Denney, Marieke Wandel, Clare M. Lloyd, Donna E. Davies, Hans Michael Haitchi
- Histamine-driven responses are sustained via a bioactive metabolite
- Tania E. Velez, Adam J. Byrne, Joshua B. Wechsler, Rebecca A. Krier-Burris, Kathryn E. Hulse, Paul J. Bryce
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?